Document Detail


Penetratin-Mediated Delivery Enhances the Antitumor Activity of the Cationic Antimicrobial Peptide Magainin II.
MedLine Citation:
PMID:  23286306     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Cationic antimicrobial peptides (CAPs) with antitumor activity have potential for use as novel antitumor agents because of their lower risk for induction of resistance. Of these peptides, magainin II (MG2) exhibited cytotoxicity in tumor cells only at high concentrations, likely due to the inefficiency of MG2 in cell membrane binding and cell entry. Conjugation to a cell-penetrating peptide (CPP) might enhance the cytotoxicity of MG2 in tumor cells. Here, we constructed a fusion peptide MG2A by conjugating MG2 to the N-terminus of the CPP penetratin (Antp). It was found that the fusion peptide MG2A is more potent than unconjugated MG2 at tumor cell killing. The IC50s of MG2A for the tumor cells tested were at least 30 times lower than the IC50s of unconjugated MG2. These data indicate that conjugation to Antp significantly enhanced the cytotoxicity of MG2 in tumor cells. Moreover, the IC50s of MG2A for tumor cells are within 2 to 3 μM, which are about three to five times lower than the IC50 for normal cells. Furthermore, chondroitin sulfate (CS) was found to be overexpressed on the surface of the tested tumor cells, and the cytotoxicity of MG2A could be inhibited by the addition of exogenous CS. These results suggest that binding of Antp to CS on tumor cells might be one important cause for the selective cytotoxicity of MG2A in tumor cells. Taken together, conjugation of MG2 to Antp can significantly enhance its antitumor activity, and the fusion of CAP to Antp might be an alternative for cancer-targeted therapy.
Authors:
Shan Liu; Hao Yang; Lin Wan; Jingqiu Cheng; Xiaofeng Lu
Related Documents :
20037826 - Expression of hypoxia-inducible factor-1alpha in liver tumors after transcatheter arter...
25367186 - Bispecific t-cell engagers for cancer immunotherapy.
18610746 - Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using...
8910916 - Inhibition of mnng-induced gastroduodenal carcinoma in rats by synchronous application ...
18464916 - Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological age...
2159846 - Tumor cell implantation with the use of gelaspon gelatin sponge disc.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Cancer biotherapy & radiopharmaceuticals     Volume:  -     ISSN:  1557-8852     ISO Abbreviation:  Cancer Biother. Radiopharm.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9605408     Medline TA:  Cancer Biother Radiopharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Key Lab of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University , Chengdu 610041, China .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chromatic Aberration Short-wave Infrared Spectroscopy: Nanoparticle Spectra without a Spectrometer.
Next Document:  Catalysis of a new ribose carbon-insertion reaction by the molybdenum cofactor biosynthetic enzyme M...